Jeffrey Lo

642 citations
6 papers · 62 indexed · h-index 4
Topics
interferon and immune responses (1 paper)Kawasaki Disease and Coronary Complications (1 paper)Drug-Induced Adverse Reactions (1 paper)

In The Last Decade

Jeffrey Lo

5 papers receiving 61 citations

Peers

Jeffrey Lo
Comparison fields: 5 of 33
  • Immunology 34
  • Rheumatology 29
  • Molecular Biology 21
  • Surgery 8
  • Radiology, Nuclear Medicine and Imaging 8
Replace Maasa Tamura with:
Maasa Tamura Japan
David Baudry France
Charlotte Thompson United Kingdom
Jimeng Xue China
Dina F. El‐Essawi Egypt
Sai Murng United Kingdom
Harumi Shirai Japan
Tai Wai Yeo Singapore
M Baleva Bulgaria
Haruyuki Yanaoka Japan
Jeffrey Lo relative to Maasa Tamura Japan Maasa Tamura's profile →
Citations per field
00.5×
Maasa Tamura · 1×
Citations per year

Countries citing papers authored by Jeffrey Lo

Since Specialization
Citations

This map shows the geographic impact of Jeffrey Lo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey Lo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey Lo more than expected).

Fields of papers citing papers by Jeffrey Lo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey Lo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey Lo. The network helps show where Jeffrey Lo may publish in the future.

Co-authorship network of co-authors of Jeffrey Lo

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey Lo. A scholar is included among the top collaborators of Jeffrey Lo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey Lo. Jeffrey Lo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
#WorkIndexed citations
1 19
2 0
3 3
4 14
5
Sex differences in pediatric systemic lupus erythematosus: a retrospective analysis of 135 cases.
21
6
Clinical observations of erythema multiforme in children.
5

About Jeffrey Lo

Jeffrey Lo is a scholar working on Nephrology, Rheumatology and General Economics, Econometrics and Finance, having authored 6 papers that have together received 62 indexed citations. Recurring topics across this work include interferon and immune responses (1 paper), Kawasaki Disease and Coronary Complications (1 paper) and Drug-Induced Adverse Reactions (1 paper). The work is most often cited by research in Rheumatology (29 citations), Immunology (34 citations) and Hematology (6 citations). Jeffrey Lo has collaborated with scholars based in United States, Canada and Brazil. Frequent co-authors include Ming‐Jen Tsai, Bor‐Luen Chiang, Yu‐Tsan Lin, Yao‐Hsu Yang, Fatma Dedeoğlu, Christina Yee, William Brucker, Matthew M. Heeney, Stacy E. Croteau and Olaf A. Bodamer. Their work appears in journals such as Frontiers in Immunology, The Journal of Pediatrics and Journal of Inherited Metabolic Disease.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026